Abstract
On August 14th, 2009, for the first time, the FDA has approved a psychotropic medication for two indications simultaneously. Saphris (asenapine) is a multitarget atypical antipsychotic medication approved to treat adults with schizophrenia and bipolar I disorder.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 263-264 |
| Number of pages | 2 |
| Journal | ACS Chemical Neuroscience |
| Volume | 1 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 21 2010 |
| Externally published | Yes |
ASJC Scopus subject areas
- Biochemistry
- Physiology
- Cognitive Neuroscience
- Cell Biology